PI3K inhibition in preclinical models of HNSCC

被引：0
|
作者：
Hedberg, Matthew Louis [1 ]
Li, Hua [1 ]
Zeng, Yan [1 ]
Grandis, Jennifer Rubin [1 ]
机构：
[1] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA
来源：
MOLECULAR CANCER THERAPEUTICS | 2015年 / 14卷 / 07期
关键词：
D O I：
10.1158/1538-8514.PI3K14-A39
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A39
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Downregulation of MYCN through PI3K inhibition in mouse models of pediatric neural cancer
    Cage, Tene Aneka
    Chanthery, Yvan
    Chesler, Louis
    Grimmer, Matthew
    Knight, Zachary
    Shokat, Kevan
    Weiss, William A.
    Gustafson, W. Clay
    FRONTIERS IN ONCOLOGY, 2015, 5
  • [32] Concurrent inactivation of PI3K and PLK1 is synergistic and overcomes acquired resistance to PI3K inhibitors in NOTCH1MUT HNSCC
    Shah, Pooja A.
    Mazumdar, Tuhina
    Powell, Reid T.
    Shen, Li
    Wang, Jing
    Stephen, Clifford C.
    Frederick, Mitchell J.
    Johnson, Faye M.
    CANCER RESEARCH, 2023, 83 (07)
  • [33] Regulation of T cell alloimmunity by PI3Kγ and PI3Kδ
    Mayuko Uehara
    Martina M. McGrath
    Shunsuke Ohori
    Zhabiz Solhjou
    Naima Banouni
    Sujit Routray
    Catherine Evans
    Jonathan P. DiNitto
    Abdallah Elkhal
    Laurence A. Turka
    Terry B. Strom
    Stefan G. Tullius
    David G. Winkler
    Jamil Azzi
    Reza Abdi
    Nature Communications, 8
  • [34] Essential role of PI3Kδ and PI3Kγ in thymocyte survival
    Swat, W
    Montgrain, V
    Doggett, TA
    Douangpanya, J
    Puri, K
    Vermi, W
    Diacovo, TG
    BLOOD, 2006, 107 (06) : 2415 - 2422
  • [35] The essential role of PI3Kδ and PI3Kγ in thymocyte survival
    Diacovo, Thomas
    Montgrain, Vivianne
    Doggett, Teresa
    Douangpanya, Jason
    Puri, Kamal
    Vermi, William
    Swat, Wojciech
    JOURNAL OF IMMUNOLOGY, 2006, 176 : S313 - S313
  • [36] Inhibition of PI3Kδ Improves Systemic Lupus in Mice
    Wang, Yanxia
    Zhang, Lei
    Wei, Ping
    Zhang, Huailiang
    Liu, Cuijie
    INFLAMMATION, 2014, 37 (03) : 978 - 983
  • [37] PI3Kδ and PI3Kγ as Targets for Autoimmune and Inflammatory Diseases
    Cushing, Timothy D.
    Metz, Daniela P.
    Whittington, Douglas A.
    McGee, Lawrence R.
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (20) : 8559 - 8581
  • [38] Dual Pharmacological Targeting of the MAP Kinase and PI3K/mTOR Pathway in Preclinical Models of Colorectal Cancer
    Pitts, Todd M.
    Newton, Timothy P.
    Bradshaw-Pierce, Erica L.
    Addison, Rebecca
    Arcaroli, John J.
    Klauck, Peter J.
    Bagby, Stacey M.
    Hyatt, Stephanie L.
    Purkey, Alicia
    Tentler, John J.
    Tan, Aik Choon
    Messersmith, Wells A.
    Eckhardt, S. Gail
    Leong, Stephen
    PLOS ONE, 2014, 9 (11):
  • [39] PI3K pathway inhibition in GBM-is there a signal?
    Nichol, Donna
    Mellinghoff, Ingo K.
    NEURO-ONCOLOGY, 2015, 17 (09) : 1183 - 1184
  • [40] How to resist PI3Kδ inhibition: activate MAPK!
    Okkenhaug, Klaus
    BLOOD, 2021, 138 (01) : 3 - 4
12345